Discover 774 paid clinical trials in District of Columbia. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Location: Port Jefferson Station NY, Westport CT, The Bronx NY,
Sponsor: Boston Scientific Corporation
Sex: All
Age: 18+
Code: NCT06827262
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Nectero EAST System Clinical Study
for
Abdominal Aortic Aneurysm
Location: Scarborough ME, Boston MA, Worcester MA, Lebanon NH,
Sponsor: Nectero Medical, Inc.
Sex: All
Age: 21 - 70+
Code: NCT06001918
Phase 2, Phase 3, Recruiting
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
for
Lewy Body Dementia Psychosis
Location: Washington D.C. DC, Richmond VA, Boca Raton FL,
Sponsor: ACADIA Pharmaceuticals Inc.
Sex: All
Age: 55 - 70+
Code: NCT07029581
Phase 2, Recruiting
Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
for
Metabolic Disease, Obesity, Li-Fraumeni Syndrome,
Location: Washington D.C. DC, Bethesda MD
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Sex: All
Age: 1 - 70+
Code: NCT01143454
Recruiting
Pragmatic Clinic-Based Trial of a Mindfulness Based Intervention for Mood Concerns in Youth With Type 1 Diabetes
for
Type 1 Diabetes (T1D)
Location: Washington D.C. DC
Sponsor: Children's National Research Institute
Sex: All
Age: 13 - 17
Code: NCT06618027
Recruiting
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
for
Aortic Regurgitation, Aortic Valve Insufficiency,
Location: Boston MA, New York NY, New Brunswick NJ,
Sponsor: JenaValve Technology, Inc.
Sex: All
Age: 0+
Code: NCT06608823
Recruiting
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
for
B Acute Lymphoblastic Leukemia
Location: Halifax, Scarborough ME, Boston MA, Providence RI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 46
Code: NCT06124157
Phase 2, Recruiting
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
for
Agitation, Alzheimer Disease
Location: Foxborough MA, Manhasset NY, Toms River NJ,
Sponsor: Celgene
Sex: All
Age: 55 - 70+
Code: NCT06808984
Phase 2, Recruiting
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
for
Pancreatic Neuroendocrine Tumor (pNET),
Location: Boston MA, New York NY, Philadelphia PA,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT06943755
Phase 2, Phase 3, Recruiting
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
for
Recurrent Langerhans Cell Histiocytosis,
Location: Halifax, Hartford CT, New Haven CT, Quebec, Sherbrooke,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 22
Code: NCT05828069
Phase 2, Recruiting
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
Video-Based Patient Navigation to Support Cervical Cancer Screening Among Black Women
for
Uterine Cervical Neoplasms
Location: Washington D.C. DC
Sponsor: ISA Associates, Inc.
Sex: Female
Age: 21 - 65
Code: NCT07011836
Recruiting
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
for
Endometrial Cancer
Location: St. John's, Scarborough ME, Boston MA, Providence RI,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT06952504
Phase 3, Recruiting
Efficacy of a Novel Prototype Gastrostomy Tube Anchor Dressing
for
Gastroenterology Surgery, Tube Feeding
Location: Washington D.C. DC
Sponsor: Children's National Research Institute
Sex: All
Age: 7 - 21
Code: NCT07115134
Recruiting
Vision Improvement Through Behavioral Rehabilitation And Neuroplasticity Training
for
Visual Field Defect, Stroke, Hemianopia, Quadrantanopia,